Pancreatic Cancer Research

ResearcherShariati HospitalActive in the last 2 years

Sahar Masoudi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0135-0307; OpenAlex author ID A5047799517. Sources: OpenAlex.

Their work

Papers
10 (first author 5, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: 4 papers · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 10

  1. The association of dietary intake and plasma fatty acid panel in pancreatic cancer patients: Results from Golestan cohort study. First author DOI 10.1177/02601060221114712↗
  2. Aspirin Use and Risk of Pancreatic Ductal Adenocarcinoma: A Large Case-Control Study. First author DOI 10.34172/aim.2023.28↗
  3. Circulating plasma fatty acids and risk of pancreatic cancer: Results from the Golestan Cohort Study. Co-author DOI 10.1016/j.clnu.2020.09.002↗
  4. Dietary intake of fatty acids and risk of pancreatic cancer: Golestan cohort study. First author DOI 10.1186/s12937-021-00723-3↗
  5. Diabetes Mellitus, Obesity, and Risk of Pancreatic Ductal Adenocarcinoma: a Large Case-Control Study from Iran. First author DOI 10.34172/mejdd.2021.198↗
  6. Diagnostic Significance of Serum Fatty Acid Synthase in Patients with Pancreatic Cancer. Co-author DOI 10.34172/mejdd.2021.214↗
  7. Survival features, prognostic factors, and determinants of diagnosis and treatment among Iranian patients with pancreatic cancer, a prospective study. First author DOI 10.1371/journal.pone.0243511↗
  8. An Increased Level of Aryl Hydrocarbon Receptor in Patients with Pancreatic Cancer. Co-author DOI 10.15171/mejdd.2018.126↗
  9. Mutations in Known and Novel cancer Susceptibility Genes in Young Patients with Pancreatic Cancer. Co-author PMID 29940740↗
  10. Menstrual and Reproductive Factors and Risk of Pancreatic Cancer in Women. Co-author DOI 10.15171/mejdd.2017.65↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Akram Pourshams Md · 9 shared papers, 2017–2024 · strength 1.20
  2. Neda Ghamarzad Shishavan · 6 shared papers, 2017–2024 · strength 0.86
  3. Ashraf Mohamadkhani · 6 shared papers, 2018–2024 · strength 0.86
  4. Azita Hekmatdoost · 3 shared papers, 2021–2024 · strength 0.51
  5. Zahra Momayez Sanat · 3 shared papers, 2017–2023 · strength 0.46
  6. Hamid Reza Fazli · 2 shared papers, 2019–2021 · strength 0.25
  7. Akram Porshams · 1 shared paper, 2023 · strength 0.22
  8. Paul Brennan · 1 shared paper, 2020 · strength 0.10
  9. Mahdi SHEIKH · 1 shared paper, 2020 · strength 0.10
  10. Saman Nikeghbalian · 1 shared paper, 2020 · strength 0.10
  11. Paolo Boffetta · 1 shared paper, 2018 · strength 0.09
  12. Sarah Mirzaie · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.